News
September 8, 2023

LOINC® from Regenstrief to host semiannual conference Oct. 17-20 in Atlanta, Georgia

LOINC® from Regenstrief Institute, a global healthcare terminology standard, is hosting its semiannual conference October 17-20, 2023, in Atlanta, Georgia.

LOINC®, which stands for Logical Observation Identifiers Names and Codes, is a standard for identifying health measurements, observations, and documents. Created and maintained at Regenstrief Institute, LOINC enables the identification, exchange and collection of data across health systems and is used around the world.

Experts focused on addressing health data interoperability issues will gather at the 2023 LOINC Conference for four days of education, community presentation and networking. Software and device manufacturers, healthcare providers, patients, reference labs, government agencies, researchers, students and others will participate.

Registration for the conference gains access to presentations. Content will include:

  • a framework for newer users and to bolster knowledge for advanced users;
  • sessions led by LOINC community members who are applying and administering LOINC codes in the field;
  • committee meetings to discuss healthcare trends and the impact on LOINC and other data standards; and
  • access to conference resources after the event.

To view the preliminary schedule, register for the conference and access a sampling of past workshops and presentations from LOINC’s most recent conference in March 2023, visit the LOINC conference website.

About LOINC®
LOINC® was created in 1994 at Regenstrief Institute to facilitate interoperability in healthcare. There was a growing trend to send clinical data electronically between healthcare entities, a practice that has now become ubiquitous. Today, it contains more than 100,000 terms for everything from an albumin level to a zygomatic arch X-ray report. For each concept, LOINC contains many other rich details, such as synonyms, units of measure, and carefully crafted descriptions.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform clinical practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Dr. Babar Khan on All IN

Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial

Published in JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Babar Khan, M.D., M.S.,

Expanding health equity by including nursing home residents in clinical trials

INDIANAPOLIS – Clinical trials are constantly being designed and study participants enrolled to determine if medical treatments and therapies

photo background showing data, etc.

Regenstrief Institute will host collaborative conference to improve public health data

Due to previous year’s high demand, virtual attendance option added  The Public Health Informatics Program in the Center for

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

But significant numbers of those living with these diseases don’t receive this treatment INDIANAPOLIS – Chlamydia and gonorrhea are